HIGHLIGHTS
- who: Zhijian Zheng from the Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China have published the Article: Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis, in the Journal: BMC Medicine
- what: Having known that AC092894.1 affects which is the manifestation of RASGRP3 the messenger RNA stage, to investigate this hypothesis, the authors aimed to determine if AC092894.1 has any effect on RASGRP3 transcriptional activity.
- how: The authors identified a novel lncRNA AC092894.1 localized on human chromosome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.